Medicare Enrolled
Dr. Hema Vankayala, MD
Internal Medicine · Fleming Island, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vankayala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vankayala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vankayala
Dr. Hema Vankayala is an internal medicine specialist in Fleming Island, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vankayala performed 10,628 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Vankayala received a total of $2,056 from 44 pharmaceutical and/or device companies across 137 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vankayala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 3% volume in FL
$2,056 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 132894 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗10,628
Medicare services
Top 3% in FL for internal medicine
Not available
Unique patients (not deduplicated)
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,700 | $18 | $40 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,130 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
905 | $8 | $18 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
765 | $8 | $41 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
384 | $13 | $43 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
363 | $63 | $104 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
322 | $93 | $162 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
249 | $22 | $90 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
187 | $10 | $42 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
158 | $96 | $355 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
88 | $47 | $160 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
83 | $15 | $55 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
73 | $1 | $7 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
54 | $12 | $55 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $129 | $265 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
34 | $1 | $4 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
31 | $10 | $40 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
24 | $61 | $115 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
23 | $3 | $15 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $103 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.4% high complexity
71.2% medium
23.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,056
Total received (2018-2024)
Avg $294/year across 7 years
Top 26% in FL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
137
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$808
2023
$208
2022
$95
2021
$118
2020
$61
2019
$471
2018
$295
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$228
PFIZER INC.
$123
SEAGEN INC.
$100
Janssen Biotech, Inc.
$49
Eisai Inc.
$38
Daiichi Sankyo Inc.
$36
Celgene Corporation
$33
Gilead Sciences, Inc.
$26
ARRAY BIOPHARMA INC
$24
GENZYME CORPORATION
$19
Tempus AI, Inc
$17
Alexion Pharmaceuticals, Inc.
$16
Incyte Corporation
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme LLC
$15
SOBI, INC
$14
Agios Pharmaceuticals, Inc.
$13
JAZZ PHARMACEUTICALS INC.
$13
GlaxoSmithKline, LLC.
$13
Top 3 companies account for 55.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$365
Janssen Biotech, Inc.
$220
PFIZER INC.
$173
Merck Sharp & Dohme Corporation
$164
SEAGEN INC.
$100
AbbVie, Inc.
$72
Eisai Inc.
$66
Celgene Corporation
$54
EISAI INC.
$53
Astellas Pharma US Inc
$47
Incyte Corporation
$42
Aurobindo Pharma USA, Inc.
$41
Gilead Sciences, Inc.
$38
Foundation Medicine, Inc.
$38
Daiichi Sankyo Inc.
$36
G1 Therapeutics, Inc.
$36
EMD Serono, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$33
Alexion Pharmaceuticals, Inc.
$30
Genentech USA, Inc.
$30
Agios Pharmaceuticals, Inc.
$27
Merck Sharp & Dohme LLC
$27
GlaxoSmithKline, LLC.
$24
ARRAY BIOPHARMA INC
$24
Karyopharm Therapeutics Inc.
$19
Amgen Inc.
$19
GENZYME CORPORATION
$19
TerSera Therapeutics LLC
$18
Octapharma USA, Inc.
$17
Tempus AI, Inc
$17
Rigel Pharmaceuticals, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
SOBI, INC
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
AMAG Pharmaceuticals, Inc.
$13
JAZZ PHARMACEUTICALS INC.
$13
AstraZeneca Pharmaceuticals LP
$13
Array BioPharma Inc.
$13
SERVIER PHARMACEUTICALS LLC
$13
Lilly USA, LLC
$12
Pharmacyclics LLC, An AbbVie Company
$11
Ipsen Biopharmaceuticals, Inc
$11
Janssen Pharmaceuticals, Inc
$8
Heron Therapeutics, Inc.
$7
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
ALIMTA · BOSULIF · BRAFTOVI · Bavencio · Braftovi · CINVANTI · COSELA · DARZALEX · ELREXFIO · EMEND · ENJAYMO · Enhertu · Erleada · FERAHEME · FOUNDATIONONE · Fabhalta · Folotyn · IBRANCE · IMBRUVICA · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · LUTATHERA · Lenvima · Lunsumio · MEKINIST · MONJUVI · NINLARO · OJJAARA · OPDUALAG · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Phesgo · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SANDOSTATIN LAR · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · Stivarga · TABRECTA · TASIGNA · TIBSOVO · TIVDAK · ULTOMIRIS · VONJO · VYNDAQEL · Vectibix · Venclexta · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XPOVIO · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
920
County median income
$86,094
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA ORANGE PARK HOSPITAL
5.3 mi
5.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vankayala is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vankayala experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Vankayala performed 5,700 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vankayala receive payments from pharmaceutical companies?
Yes. Dr. Vankayala received a total of $2,056 from 44 companies across 137 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vankayala's costs compare to other internal medicine physicians in Fleming Island?
Dr. Vankayala's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vankayala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Fleming Island
Browse internal medicine physicians in Fleming Island ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in FL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in FL
Which FL internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology